companies / amissa-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-02 json
| total_raised | 2,523,3492.5M | ○ |
|---|---|---|
| founded | 2017 | |
| hq | CHARLOTTE, North Carolina | |
| industry | unknown | |
| stage | null |
Amissa converts menopause symptoms and wearable signals into EHR-ready clinical documentation grounded in the Menopause Rating Scale. It serves clinicians, perimenopausal patients and women-health researchers. NIH funding and Harvard, MGH and Pitt collaborations anchor the scoring beyond consumer-app heuristics.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 2,523,3492.5M | null | ○ |
Vercel, HeroUI, Contentful, Vercel Speed Insights, Next.js 16.0.10, Webpack, PostHog 1.364.2, @heroicons/react 2.2.0, fflate 0.4.8, class-variance-authority 0.7.1, uuid 10.0.0, @payloadcms/richtext-lexical 3.37.0
| fact | status | src |
|---|---|---|
| Grant, $2.5M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |